Drug Shortage Report for 0.9% SODIUM CHLORIDE INJECTION, USP
| Report ID | 98688 |
| Drug Identification Number | 00060208 |
| Brand name | 0.9% SODIUM CHLORIDE INJECTION, USP |
| Common or Proper name | 0.9% SODIUM CHLORIDE INJECTION, USP |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | SODIUM CHLORIDE |
| Strength(s) | 900MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 500 mL (JB1323) |
| ATC code | B05XA |
| ATC description | I.V. SOLUTION ADDITIVES |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2019-11-14 |
| Actual start date | 2019-11-14 |
| Estimated end date | 2019-12-17 |
| Actual end date | 2019-12-17 |
| Shortage status | Resolved |
| Updated date | 2019-12-18 |
| Company comments | |
| Health Canada comments | |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.